EVOQ Remedies Ltd.

Financial

	EVOQ Remedies	JFL Life Sciences	Deccan Health Care
Operational Metrics
Financials
5 yr Average ROE	22.13 %	11.5 %	0.71 %
5yr average Equity Multiplier	53.05	3.23	1.17
5yr Average Asset Turnover Ratio	0.81	0.95	0.44
5yr Avg Net Profit Margin	6.55 %	4.98 %	1.32 %
Price to Book	0.0	1.12	0.42
P/E	97.05	10.67	43.2
5yr Avg Cash Conversion Cycle	764.12 Days	217.93 Days	287.43 Days
Inventory Days	54.66 Days	85.64 Days	412.47 Days
Days Receivable	853.76 Days	186.74 Days	66.84 Days
Days Payable	175.72 Days	98.82 Days	105.94 Days
5yr Average Interest Coverage Ratio	2684.0	3.02	10.45
5yr Avg ROCE	29.72 %	18.94 %	2.21 %
5yr Avg Operating Profit Margin	-8.09 %	9.53 %	8.19 %
5 yr average Debt to Equity	0.24	1.19	0.02
5yr CAGR Net Profit	n/a	55.85 %	30.74 %
5yr Average Return on Assets	3.61 %	4.15 %	0.62 %
Shareholdings
Promoter Holding	11.21 %	67.47 %	18.42 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	-62.32 %	0.0	-16.47 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0

Business

	EVOQ Remedies	JFL Life Sciences	Deccan Health Care
Product Wise Break-Up	Product Wise Break-Up Pharmaceuticals 100.0 Pharmaceutical Products 0 0	Product Wise Break-Up Pharmaceuticals 100.0 Pharmaceuticals 0 0	Product Wise Break-Up Pharmaceutical Products 0 Pharmaceuticals 0 Fast Moving Consumer Health Products FMCHP) 100.0
Location Wise Break-Up	Location Wise Break-Up India 100.0 Rest of the World 0	-	Location Wise Break-Up Rest of the World 0.29 India 99.71